Share Email Print
cover

Proceedings Paper

Fluorescence analysis of ubiquinone and its application in quality control of medical supplies
Author(s): Elvira O. Timofeeva; Elena V. Gorbunova; Aleksandr N. Chertov
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The presence of antioxidant issues such as redox potential imbalance in human body is a very important question for modern clinical diagnostics. Implementation of fluorescence analysis into optical diagnostics of such wide distributed in a human body antioxidant as ubiquinone is one of the steps for development of the device with a view to clinical diagnostics of redox potential. Recording of fluorescence was carried out with spectrometer using UV irradiation source with thin band (max at 287 and 330 nm) as a background radiation. Concentrations of ubiquinone from 0.25 to 2.5 mmol/l in explored samples were used for investigation. Recording data was processed using correlation analysis and differential analytical technique. The fourth derivative spectrum of fluorescence spectrum provided the basis for a multicomponent analysis of the solutions. As a technique in clinical diagnostics fluorescence analysis with processing method including differential spectrophotometry, it is step forward towards redox potential calculation and quality control in pharmacy for better health care.

Paper Details

Date Published: 17 February 2017
PDF: 11 pages
Proc. SPIE 10072, Optical Diagnostics and Sensing XVII: Toward Point-of-Care Diagnostics, 100720N (17 February 2017); doi: 10.1117/12.2252879
Show Author Affiliations
Elvira O. Timofeeva, ITMO Univ. (Russian Federation)
Elena V. Gorbunova, ITMO Univ. (Russian Federation)
Aleksandr N. Chertov, ITMO Univ. (Russian Federation)


Published in SPIE Proceedings Vol. 10072:
Optical Diagnostics and Sensing XVII: Toward Point-of-Care Diagnostics
Gerard L. Coté, Editor(s)

© SPIE. Terms of Use
Back to Top